(Q83841668)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Conversion to proliferation signal inhibitors-based immunosuppressive regimen in kidney transplantation: to whom and when? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

main subject

kidney transplantation

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

S Sahin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

A Gürkan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

M Uyar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

V Turunç

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

C Varilsuha

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

S Kaçar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

837-840

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

Calcineurin inhibitor-free immunosuppression in kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

Everolimus in clinical practice--renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

A randomized long-term trial of tacrolimus/sirolimus versus tacrolimums/mycophenolate versus cyclosporine/sirolimus in renal transplantation: three-year analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

Mycophenolate mofetil and sirolimus combination in renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

Proteinuria following a switch from calcineurin inhibitors to sirolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

De novo everolimus-based therapy in renal transplant recipients: effect on proteinuria and renal prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

mTOR inhibitor-associated dermatologic and mucosal problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: a three-year phase II, randomized, multicenter, open-label study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.097

10.1016/J.TRANSPROCEED.2011.01.097

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21486610%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference